Pfizer’s new drug for a rare heart disease – Vyndaqel – has shattered analysts’ sales forecasts in its first quarter on the market and looks set to quickly enter blockbuster territory. Five months ...
Radiopharmaceuticals are a rapidly advancing class of radioactive compounds with diagnostic and therapeutic applications. In this article, we focus on the supply chain and how players, current and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback